Caris Life Sciences, Inc.
CAI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 6/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $24,325 | -$71,789 | -$102,581 | -$66,186 |
| Dep. & Amort. | $7,333 | $6,409 | $7,045 | $11,610 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $13,655 | $28,293 | $14,691 | $4,485 |
| Change in WC | $13,358 | -$1,439 | $13,321 | -$4,117 |
| Other Non-Cash | $3,754 | $45,814 | $36,186 | -$8,718 |
| Operating Cash Flow | $62,425 | $7,288 | -$31,338 | -$62,926 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7,095 | -$1,386 | -$2,689 | -$2,588 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$7,095 | -$1,386 | -$2,689 | -$2,588 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$23 | $23,843 | -$22 | -$30 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$16,560 | $0 | -$22 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$4,514 | $129,100 | $1,329 | -$99 |
| Financing Cash Flow | -$21,097 | $681,402 | $1,285 | -$129 |
| Forex Effect | $62 | $93 | $4 | $12 |
| Net Chg. in Cash | $34,295 | $687,397 | -$32,738 | -$65,631 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $722,687 | $35,290 | $68,028 | $245,829 |
| End Cash | $756,982 | $722,687 | $35,290 | $180,198 |
| Free Cash Flow | $55,330 | $5,902 | -$34,027 | -$65,514 |